Te Ahumairangi Investment Management Ltd Decreases Holdings in HCA Healthcare, Inc. $HCA

Te Ahumairangi Investment Management Ltd cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 28.8% during the 3rd quarter, HoldingsChannel reports. The firm owned 13,641 shares of the company’s stock after selling 5,505 shares during the quarter. Te Ahumairangi Investment Management Ltd’s holdings in HCA Healthcare were worth $5,814,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Cerity Partners LLC lifted its position in shares of HCA Healthcare by 13.1% during the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after purchasing an additional 5,092 shares in the last quarter. Swiss National Bank lifted its holdings in HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after buying an additional 23,100 shares in the last quarter. National Pension Service grew its stake in shares of HCA Healthcare by 2.9% during the third quarter. National Pension Service now owns 626,585 shares of the company’s stock valued at $267,051,000 after acquiring an additional 17,531 shares in the last quarter. Savant Capital LLC increased its position in shares of HCA Healthcare by 37.7% during the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after acquiring an additional 1,246 shares during the last quarter. Finally, Sector Gamma AS boosted its holdings in HCA Healthcare by 36.0% in the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after purchasing an additional 2,883 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the sale, the senior vice president directly owned 11,993 shares in the company, valued at $6,171,357.94. The trade was a 40.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 15,214 shares of company stock worth $7,797,595 in the last 90 days. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded up $1.14 during trading on Friday, reaching $533.72. 219,850 shares of the company’s stock traded hands, compared to its average volume of 1,114,783. The company has a 50 day moving average of $505.79 and a 200-day moving average of $468.65. HCA Healthcare, Inc. has a 12 month low of $313.21 and a 12 month high of $556.52. The stock has a market capitalization of $119.35 billion, a P/E ratio of 18.80, a price-to-earnings-growth ratio of 1.65 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating the consensus estimate of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business’s revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the company earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Analysts Set New Price Targets

Several equities analysts have recently commented on HCA shares. Deutsche Bank Aktiengesellschaft increased their target price on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Oppenheimer increased their price objective on shares of HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Wednesday, January 28th. Leerink Partners upped their target price on shares of HCA Healthcare from $507.00 to $573.00 and gave the company an “outperform” rating in a research note on Wednesday, January 28th. Zacks Research lowered HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Finally, Wall Street Zen downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $537.73.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.